Dianthus Therapeutics, Inc. Common Stock (DNTH) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DNTH. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 7,767,686 | $652M | INCREASED |
| BlackRock, Inc. | 3,175,703 | $267M | INCREASED |
| RA CAPITAL MANAGEMENT, L.P. | 2,611,733 | $219M | INCREASED |
| WELLINGTON MANAGEMENT GROUP LLP | 2,595,783 | $218M | INCREASED |
| Fairmount Funds Management LLC | 2,537,191 | $213M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Adam M Veness (SVP, General Counsel and Sec.) | EXERCISE | 30,000 | $536K | 2026-06-17 |
| Adam M Veness (SVP, General Counsel and Sec.) | SELL | 13,229 | $1M | 2026-06-17 |
| Adam M Veness (SVP, General Counsel and Sec.) | SELL | 16,771 | $1M | 2026-06-17 |
| Simrat Randhawa (EVP, Head of R&D) | EXERCISE | 9,375 | $207K | 2026-06-01 |
| Simrat Randhawa (EVP, Head of R&D) | EXERCISE | 6,249 | $136K | 2026-06-01 |
Full institutional holdings, insider history, and congressional trades for Dianthus Therapeutics, Inc. Common Stock on SentiSense.